Skip to main content

Currently Skimming:

Appendix A: Glossary
Pages 123-126

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 123...
... Food and Drug Administration, including vaccines, blood and blood components, allergenic compounds, somatic cells, gene therapy, tissues, and recombinant therapeutic proteins. Biosimilar -- A biological drug that is very much like another biological drug (called the reference drug)
From page 124...
... -- A formal study carried out according to a prospectively defined protocol that is intended to discover or verify the safety and the effectiveness of procedures or interventions in humans. Clinician-administered drug -- An outpatient drug other than a vaccine that is typically administered by infusion or injection by a health care provider in a physician's office or other outpatient clinical setting.
From page 125...
... Federally qualified health centers -- Community-based health care providers that receive funds from the Health Resources and Services Administra­tion Health Center Program to provide primary care services in underserved areas. Fee-for-service system -- A system of health insurance payment in which health care providers are reimbursed for each particular service rendered on the basis of the number of services they provide.
From page 126...
... Vial sharing -- The practice of using residual drug from a vial to treat other patients within an acceptable time frame. Waste -- For efficiency in health care spending, waste refers to any spending that does not produce as much value as it could have if it were directed differently.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.